Evoke Pharma (EVOK) Misses Q1 EPS by 20c

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.37), $0.20 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• Qualcomm expects $40bn in non-handset revenue by fiscal 2029